Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 9/20 | 0.44 |
| ▸ | PPARA | Q07869 | 5/20 | 0.44 |
| ▸ | TERT | O14746 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | PPARD | Q03181 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5821498 | 0.84 | DGKA (0.47) | PPARGPPARAPTPN1PPARDMAPT | |
| Ethylene Glycol SCHEMBL14958387 | 0.83 | PPARG (0.42) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL28218359 | 0.82 | FAAH (0.50) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL7970049 | 0.78 | EPHX2 (0.49) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL11130007 | 0.77 | EP300 (0.45) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL11005625 | 0.77 | EP300 (0.45) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL11805820 | 0.77 | EP300 (0.45) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL1502818 | 0.77 | EP300 (0.45) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL11130016 | 0.77 | EP300 (0.45) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL11005612 | 0.77 | EP300 (0.45) | PPARGPPARATERTPTPN1PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3073263-B1 | DEVICE, COMPOSITION AND METHOD FOR TISSUE-BASED DIAGNOSIS | UNIV CALIFORNIA (US) | 2020-04-29 | — | — | EP | claimed |
| US-9848853-B2 | System, method and devices for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-12-26 | — | — | US | claimed |
| EP-3073263-A1 | SYSTEM, METHOD AND DEVICE FOR TISSUE-BASED DIAGNOSIS | The Regents of the University of California (US) | 2016-09-28 | — | — | EP | claimed |
| US-20160235392-A1 | SYSTEM, METHOD AND DEVICES FOR TISSUE-BASED DIAGNOSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-08-18 | — | — | US | claimed |
| US-9328324-B2 | System, method and devices for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-05-03 | — | — | US | claimed |
| US-20150344834-A1 | System, Method and Devices for Tissue-Based Diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-12-03 | — | — | US | claimed |
| CN-104655828-A | SYSTEM, METHOD AND DEVICE FOR TISSUE-BASED DIAGNOSIS | UNIV CALIFORNIA | 2015-05-27 | — | — | CN | claimed |
| US-8945482-B2 | System, method and device for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-02-03 | — | — | US | claimed |
| EP-2575807-B1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2014-02-19 | — | — | EP | claimed |
| EP-1436435-B1 | METHOD OF ANODIZING OF MAGNESIUM AND MAGNESIUM ALLOYS AND PRODUCING CONDUCTIVE LAYERS ON AN ANODIZED SURFACE | ALONIM HOLDING AGRICULTURAL CO (IL) | 2010-04-14 | — | — | EP | claimed |
| US-20070161030-A1 | Micelle-and microemulsion-assisted planar separations platform for proteomics | PERKINELMER LAS, INC. | 2007-07-12 | — | — | US | claimed |
| WO-2007067731-A2 | MICELLE- AND MICROEMULSION-ASSISTED PLANAR SEPARATIONS PLATFORM FOR PROTEOMICS | PERKINELMER LAS, INC. (US) | 2007-06-14 | — | — | WO | claimed |
| US-9848853-B2 | System, method and devices for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-12-26 | — | — | US | disclosed |
| EP-1774276-B1 | METHODS AND COMPOSITIONS FOR DETECTING AND ISOLATING PHOSPHORYLATED MOLECULES USING HYDRATED METAL OXIDES | PERKINELMER HEALTH SCI INC (US) | 2017-06-07 | — | — | EP | disclosed |
| US-20170050044-A1 | Integumentary System Therapy | LEBOVITZ RUSSELL M (US) | 2017-02-23 | — | — | US | disclosed |
| US-9562895-B2 | Assay particles and methods of use | PERKINELMER HEALTH SCIENCES, INC. (US) | 2017-02-07 | — | — | US | disclosed |
| EP-1476121-A1 | TOPICAL IVERMECTIN COMPOSITION | Merck & Co., Inc. (US) | 2004-11-17 | — | — | EP | disclosed |
| WO-2003066009-A1 | TOPICAL IVERMECTIN COMPOSITION | MERCK & CO., INC. (US) | 2003-08-14 | — | — | WO | disclosed |
| US-5877209-A | THE ANTIOXIDANT OR FREE RADICAL BLOCKING AGENT IS ASCORBIC-ACID, BUTYLATED HYDROXYTOLUENE (BHT), BUTYLATED HYDROXYANISOLE (BHA), A MIXTURE OF ASCORBIC ACID AND BHT OR BHA OR A BLEND OF TOCOPHEROLS AND ASCORBIC ACID. | YUNIS ADEL A (US) | 1999-03-02 | — | — | US | disclosed |
| US-4673569-A | FILM FORMING POLYVINYLPYRROLIDONE WITH DIESTER OF DIETHYLENE GLYCOL AND SODIUM BENZOATE | FABERGE INCORPORATED (US) | 1987-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050044-A1 | Integumentary System Therapy | OTC, SUCLG1, TYR | PPARG 4407/4885PPARA 4317/4885TERT 2055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.